These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 457275)

  • 1. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.
    Tanaka A; Nagao S; Nagao R; Kotani S; Shiba T; Kusumoto S
    Infect Immun; 1979 May; 24(2):302-7. PubMed ID: 457275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of macrophage migration by muramyl peptides.
    Nagao S; Tanaka A; Yamamoto Y; Koga T; Onoue K; Shiba T; Kusumoto K; Kotani S
    Infect Immun; 1979 May; 24(2):308-12. PubMed ID: 457276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.
    Fraser-Smith EB; Waters RV; Matthews TR
    Infect Immun; 1982 Jan; 35(1):105-10. PubMed ID: 7054119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
    Dewhirst FE
    Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I; Theze J; Chedid L
    J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide.
    Kireszenbaum F; Ferraresi RW
    Infect Immun; 1979 Jul; 25(1):273-8. PubMed ID: 113344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrier.
    Galelli A; Le Garrec Y; Chedid L; Lefrancier P; Derrien M; Level M
    Infect Immun; 1980 Apr; 28(1):1-5. PubMed ID: 6769814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C; Juy D; Bourgeois E; Chedid L
    Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
    Löwy I; Leclerc C; Bourgeois E; Chedid L
    J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation by muramyl dipeptide (MDP) without lymphocyte participation.
    Nagao S; Miki T; Tanaka A
    Microbiol Immunol; 1981; 25(1):41-50. PubMed ID: 7253958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of immunostimulant activities of muramyl dipeptide (MDP) by linking amino-acids or peptides to the glutaminyl residue.
    Audibert F; Parant M; Damais C; Lefrancier P; Derrien M; Choay J; Chedid L
    Biochem Biophys Res Commun; 1980 Sep; 96(2):915-23. PubMed ID: 7426019
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptides.
    Bahr GM; Chedid LA; Behbehani K
    Cell Immunol; 1987 Jul; 107(2):443-54. PubMed ID: 3496165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Adam A; Souvannavong V; Lederer E
    Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines.
    Iribe H; Koga T; Onoue K; Kotani S; Kusumoto S; Shiba T
    Cell Immunol; 1981 Oct; 64(1):73-83. PubMed ID: 7028277
    [No Abstract]   [Full Text] [Related]  

  • 19. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
    McCoy DM; Brown GL; Ausobsky JR; Polk HC
    Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reticuloendothelial system activation using synthetic glycopeptides in the mouse (author's transl)].
    Hlavatá D; Masek K
    Cas Lek Cesk; 1981 Jun; 120(22):662-4. PubMed ID: 7237508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.